The neurological involvement in acute liver failure (ALF) is characterized by arousal impairment with progression to coma. There is a growing body of evidence that neuroinflammatory mechanisms play a role in this process, including production of inflammatory cytokines and microglial activation. However, it is still uncertain whether brain-derived cytokines and glial cells are crucial to the pathophysiology of ALF at the early stage, before coma development. Here, we investigated the influence of cytokines and microglia in ALFinduced encephalopathy in mice as soon as neurological symptoms were identifiable.
Introduction
Acute liver failure (ALF) is a rare but severe clinical syndrome defined by a sudden loss of hepatic function and the presence of increased circulating levels of liver enzymes, coagulopathy and overt encephalopathy (Bernal et al., 2010) . The neurological involvement in ALF is characterized by a rapid progression of arousal impairment from mild lethargy and confusion to stupor and coma (Shawcross and Wendon, 2012) . Hepatic encephalopathy is one of the major complications and causes of death in ALF, and arrives from brain edema, intracranial hypertension and cerebral herniation (Bernal et al., 2013; Vaquero et al., 2003a) . The mortality rate in ALF is about 30% and might be higher if intracranial hypertension is present. In addition, severe intracranial hypertension may also preclude emergency liver transplantation, the only definitive treatment available (Bernal et al., 2013) . A better understanding of the physiopathology of ALF and the related encephalopathy is crucial for the development of new therapies that would slow down its progression and improve clinical outcome. Encephalopathy in ALF has been considered a primary gliopathy characterized by perivascular swollen astrocytes end-feet leading to cytotoxic cerebral edema (Butterworth, 2012; Kato et al., 1992) . The genesis of astrocyte cellular edema is not completely understood, but the accumulation of ammonia due to hepatic dysfunction is considered a hallmark of its pathogenesis (Norenberg et al., 2007) . More recently a growing body of evidence has suggested that both peripheral and central nervous system inflammation may have a role in hepatic encephalopathy, acting alone or synergistically with ammonia (Butterworth, 2011 (Butterworth, , 2013 .
A significant correlation between the severity of systemic inflammatory response (resulting from hepatocyte cell death and/or infection) and the progression of ALF-induced encephalopathy has been consistently reported in experimental models and humans (Rolando et al., 2000; Vaquero et al., 2003b; Wright et al., 2007) . Serum levels of TNF-α were found increased in ALF patients and were positively correlated with intracranial hypertension, a clinical condition associated with a poor prognosis (Streetz et al., 2000; Wright et al., 2007) . The deletion of TNF-α receptor 1 (p55) delayed the onset of coma in ALF induced by the hepatotoxic drug azoxymethane in mice (Bémeur et al., 2010a) . In this same model, Chastre et al. (2012) demonstrated that the pretreatment with etanercept (a TNF-α neutralizing molecule composed of the soluble TNF-α receptor 2 -p75 -fused to the FC portion of IgG) reduced both peripheral and cerebral inflammation leading to delayed progression of hepatic encephalopathy. Other cytokines such as IL-1α and IL-6 have also been implicated in hepatic encephalopathy, and were found elevated in the brain following ALF (revised in Butterworth, 2013) . Besides the increased levels of cytokines in the brain, the activation of microglial cells was demonstrated in experimental models of ALF resulting from hepatic devascularization or azoxymethane (Bémeur et al., 2010b; Jiang et al., 2009b) . Microglial cells are the brain's innate immune cells that once activated take on an ameboid appearance secreting a range of inflammatory cytokines (Ransohoff and Cardona, 2010) . Interestingly, microglial activation was demonstrated to occur at fairly late stages of hepatic encephalopathy, suggesting that other cell types could be an earlier source of cytokines (Rangroo-Thrane et al., 2012) .
The understanding of the contribution of glial cells and brain-derived inflammatory cytokines at the early stage of the pathogenesis of ALF-induced encephalopathy may provide insights to the development of strategies to halt its development or progression. Here, we investigated the involvement of cerebral cytokines and chemokines, and of microglial activation at the early stage of hepatic encephalopathy in mice. The thioacetamide (TAA)-treated mouse model of ALF was used in this study. This model is widely used, and is well established relative to liver function, brain edema development and neurological status, resembling several pathophysiological and clinical features of the ALF in humans (Jayakumar et al., 2014; Rama Rao et al., 2014; Shmarakov et al., 2014) .
Results

TAA injection promoted a decrease on locomotor activity at different time-points
In order to detect the first signs of symptoms in TAA-treated mice, locomotor activity was assessed in different time points (12, 24, 36 and 48 h) after injection of TAA. TAA decreased locomotor activity, compared to saline administration [F(4,34)¼ 6.57, po0.001], and the most significant effect was observed at 24 h (po0.001) (Fig. 1). 
2.2.
Effect of TAA on liver morphology and hepatic function at 24 h post-injection TAA is a widely recognized hepatotoxic drug. Once in circulation, TAA is absorbed and bioactivated by hepatocytes. The accumulation of toxic metabolites will finally modify aminelipids and proteins, causing cell damage and death in the liver (Hajovsky et al., 2012) . Here we assessed liver injury and hepatic function at 24 h post TAA administration to study the temporal correlation between ALF and impairment of locomotor activity.
Histological analysis revealed that TAA injection induced centrilobular necrosis and hydropic degeneration in TAAtreated mice compared with controls ( Fig. 2A and B) . Liver damage was confirmed by elevation of ALT levels [t(10) ¼ 6.836, po0.001] (Fig. 2C) , and prolonged prothrombin and activated partial thromboplastin times [t(9)¼ 3.015, p¼ 0.014 and t(9)¼2.751, p ¼0.022, respectively) ( Fig. 2D and E) .
As described elsewhere, increase in serum levels of ammonia, mild brain edema and EEG changes compatible with metabolic encephalopathy followed TAA injection in mice (Gomides et al., 2014) . Besides liver injury and brain compromise, TAA treatment was associated with lung injury (i.e. increased cellularity, alveolar edema and hemorrhage).
2.3.
Ultrastructural alterations in the brain at 24 h postinduction of ALF In order to evaluate the occurrence of subcellular changes in the brain in parallel with the development of ALF, we carried out an ultrastructural study in mouse brain following TAA injection. Transmission electron microscopy revealed morphological abnormalities in the brain capillaries in all samples. Reactive endothelial cells with cytoplasmic projections and enlargement of perivascular astrocyte end-feet were observed in ALF-induced mice compared with controls ( Fig. 3A-D) . Also, swollen mitochondria and intracellular vacuoles were observed in glial cells of TAA-treated mice ( Fig. 3E and F) . Representative areas were chosen for the figures.
2.4.
Effects of TAA on serum and brain TNF-α, CXCL1 and CCL3 levels in 24, 36 and 48 h after TAA Fig. 5A-F) . There was an increase in TNF-α level at 36 h (po0.05), whereas IL-1β was increased at 24 h post TAA. The higher concentrations of chemokines CXCL1 (po0.01), CCL2 (po0.001), CCL3 (po0.01) and CCL5 (po0.001) were reached following 24 h of TAA. No b r a i n r e s e a r c h 1 5 7 8 ( 2 0 1 4 ) 4 9 -5 9 statistical difference was observed in the brain levels of any cytokine or chemokine at 48 h post TAA.
2.5.
Leukocyte recruitment to pial microvasculature at 24, 36 and 48 h after induction of ALF Upon activation endothelial cells can express adhesion molecules and chemoattractants that are presented on their luminal surface, leading to leukocyte-endothelium interactions. Since electron microscopic analysis revealed reactive brain endothelial cells with cytoplasmic projections to the capillary lumen concomitant with an increase of cytokines and chemokines expression in the brain, we assessed leukocyte-endothelium interactions at 24, 36 and 48 h post TAA. Intravital microscopy of pial microvasculature revealed significant increase in leukocyte rolling at 48 h in TAA-treated mice compared with controls [F(3,15)¼19.16, po0.0001] (Fig. 6A ). There was also increased leukocyte adhesion, but no statistical significance was observed [F(3,15)¼ 2.095, p¼ 0.14] (Fig. 6B ). These data provide functional evidence of endothelial cells activation, and are also in line with the lack of leukocyte recruitment into the brain of ALF mice.
2.6.
Iba-1 expression and cellular density in the brain at 24 and 36 h after induction of ALF Iba-1 is a calcium-binding protein specifically expressed in microglia in the brain. Antibodies against Iba-1 are helpful to identify microglia with details of their processes (Kettenmann et al., 2011) . Here, we did not observe any sign of activation of microglia either at 24 or at 36 h post TAA. There was no increase in cellular density in ALF-induced mice compared with controls [F(2,11)¼1.188, p¼ 0.341] (Fig. 7A  and B) . Besides, no morphological differences were observed between the groups. Microglia presented spindle-shaped cell bodies and numerous long, thin, branched processes (Fig. 7C) . 
2.7.
Activity of antioxidant enzymes was decreased in TAA-treated mice
In order to evaluate if there was any alteration in the redox state of the brain of TAA-treated mice in parallel with cytokines and chemokines up-regulation, we measured the presence of lipid peroxidation and the activity of antioxidant enzymes 24 h after TAA administration. We observed significant decrease in activity of SOD [t (4) Fig. 1A-C) . There was increased lipid peroxidation but statistical significance was not attained [t(2)¼3.758, p¼ 0.064] (Supplementary Fig. 1D ).
Discussion
We demonstrated that up-regulation of cytokines and chemokines in the brain is associated with the development of symptoms in TAA-treated mice. Locomotor activity is a clinical parameter widely used to stratify the severity of hepatic encephalopathy in experimental models (Ahboucha et al., 2008; Chang et al., 2011; Rodrigo et al., 2010) . Accordingly, locomotor activity was used to determine the most appropriate time to investigate early clinical manifestations of ALF. At 24 h, TAA-treated mice presented both the first and most significant decrease in locomotor activity in parallel with overt ALF, with increased serum levels of ammonia and liver enzymes, coagulopathy and morphological changes in astrocytes, confirming the development of ALF-induced encephalopathy. We observed that the emergence of symptoms of ALF-induced encephalopathy preceded an increase in TNF-α level, but IL-1β and chemokine levels were increased in the brain 24 h after TAA administration. These data suggest that, in the current model, the generation of IL-1β in the brain may precede that of TNF-α leading to locomotor activity impairment. TNF-α and IL-1β are strongly related to the severity of encephalopathy in a context of ALF, and interventions that are able to block both cytokines effects in experimental models resulted in significantly delay in the onset of coma and improved clinical outcomes (Bémeur et al., 2010a,b; Chastre et al., 2012; Jiang et al., 2009b) . Accordingly, IL-1β receptor knockout mice had a delayed onset of coma in azoxymethane-induced ALF encephalopathy, which was also reported in mice lacking the TNF-α receptor (Bémeur et al., 2010a,b) . Besides, hepatic devascularized rats had no elevation of IL-1β or TNF-α during the asymptomatic phase, but both cytokines were increased when rats rapidly reached the coma stage (Jiang et al., 2009a,b) .
In our model, we observed a mortality rate about 40% between 24 and 48 h after TAA injection (Miranda et al., 2010) , while other models of ALF with encephalopathy present a more severe course with onset of coma at approximately 14-20 h after induction of ALF with 100% of mortality (Bémeur et al., 2010a,b; Chastre et al., 2012; Jiang et al., 2009a, b) . The prolonged course of the current model allowed the observation of the earlier elevation of IL-1β in relation to TNF-α. In line with this finding, cultured astrocytes exposed to ammonium chloride were able to increase mRNA for IL-1β while those for TNF-α remained unchanged (Zemtsova et al., 2011) . Moreover, while the elevation of both IL-1β and TNF-α in the brain after LPS may determine locomotor activity impairment, mice lacking IL-1β converting enzyme exhibited protection from the cerebral effects of LPS without increasing TNF-α expression and with normal mobility in the forced swimming test (Lawson et al., 2013) .
We also found that the chemokines CXCL1, CCL2, CCL3 and CCL5 were increased in the symptomatic phase of our model. To the best of our knowledge, this is the first report of the influence of chemokines in experimental models of encephalopathy associated with ALF. Chemokines are involved in several neuroinflammatory conditions and can be produced by different cell types including astrocytes, microglia, neurons and brain endothelial cells. Recent studies have reported an increase in the brain levels of CXCL1, CCL2, CCL3 and CCL5 in parallel with behavior impairment in different experimental models in mice (Amaral et al., 2011; Comim et al., 2011; Pedroso et al., 2013) .
The chemokine CCL2 seems to regulate the production of inflammatory cytokines in the brain (Semple et al., 2010; Strecker et al., 2011; Thompson et al., 2008) . In an animal model of seizure, an increase in the expression of CXCL1 and CCL3 by neurons, brain endothelial cells and microglia preceded neutrophil infiltration (Johnson et al., 2011) . In ALF, the participation of granulocytes is not usual and not expected (Butterworth, 2012) and, in our model, we did not observe any leukocyte infiltration in the brain. Accordingly, we suggest that CXCL1 and CCL3 may exert their actions on brainresident cells, rather than attracting circulating peripheral leukocytes. In support of this, a previous study showed that CXCL1 induced the production of CCL2, CCL3, CCL5 and TNF-α in mice cultured astrocytes (Luo et al., 2000) . Additionally, recent studies reported that chemokines are also capable of modulating neuronal network activity and CCL2 seemed to be able to enhance GABA-evoked currents or by acting on the properties of sodium channels (Belkouch et al., 2011; Caioli et al., 2013) . Previous studies have demonstrated that in ALFinduced encephalopathy there is a neuronal dysfunction with increased activation of NMDA receptor and its blockade was associated with a significant increase in survival rate (Cauli et al., 2008) . Although most authors advocate that NMDA activation might be caused mainly by ammonia, the role of chemokines has not been investigated yet (Hermenegildo et al., 2000; Schwarz et al., 2012) . Interestingly, chronic exposure of cultured hippocampal neurons to CCL3 increased NMDA-evoked signals and NMDA receptors levels (Kuijpers et al., 2010) .
The major source of cerebral cytokines and chemokines in ALF remains to be elucidated. Jiang et al. (2009b) reported that the use of minocycline prevented microglial activation and TNF-α elevation in the brain of rats with devascularized liver, slowing the development of coma. Nevertheless, the administration of a TNF-α inhibitor to mice with drug-induced ALF prevented microglial activation, indicating a key role for TNF-α in the activation of microglia and that this cytokine would be produced earlier by another cell type (Chastre et al., 2012) . Here, we did not observe any morphological change in microglia or increase in cellular density using Iba-1 staining, suggesting that there was no overt microglial activation. Rangroo-Thrane et al. (2012) reported microglial activation only at a late stage in mice with toxic ALF-induced encephalopathy, when animals developed significant cerebral edema. Hence, astrocytes, brain endothelial cells or neurons might be involved in inflammatory cytokines upregulation at an early stage of ALF preceding microglia activation.
In fact, we observed cellular ultrastructural changes of enlarged astrocytes with mithocondrial swelling. Although cytokines and chemokines production by these cells have been poorly investigated, it is well-known that astrocytes exert a major role in the physiopathology of ALF through mithocondrial dysfunction and oxidative and nitrosative stress (Görg et al., 2008; Jayakumar et al., 2004; Rama Rao et al., 2005) . Moreover, Alvarez et al. (2011) observed that exposition of cultured astrocytes to inflammatory cytokines enhanced mithocondrial oxidative stress induction and viceversa, suggesting a synergic effect of these molecules. We also observed enhanced oxidative stress in the brain, but it remains to be determined whether astrocytes are the main responsible for this finding.
Brain endothelial cells were shown to promote astrocyte swelling when exposed to ammonia, LPS and inflammatory cytokine mixture in vitro via oxidative and nitrosative stress suggesting a role for them in ALF (Jayakumar et al., 2012) . We observed numerous cytoplasmic projections on brain endothelial cells of TAA-treated mice in parallel with increased leukocyteendothelium interaction, a process dependent on the expression of surface adhesion molecules and chemokines (Langer and Chavakis, 2009) . These findings suggest an early activation of brain endothelial cells that could contribute to the pathogenic mechanisms underlying behavioral changes in our model, including the production of IL-1β and other cytokines and chemokines. In this line, Jayakumar et al. (2014) demonstrated that brain endothelial cells significantly contributed to astrocyte swelling and, therefore, to brain edema in the TAA-induced ALF.
Our study has several limitations. It is largely descriptive, not investigating potential mechanisms of cytokine/chemokine effects on hepatic encephalopathy. The source of these inflammatory molecules in the brain during the early phase of hepatic encephalopathy also remains to be determined in the current and other experimental models of ALF. Besides the liver and the brain, other organs (e.g. kidney) can be affected by TAA treatment which was not assessed. This issue and a potential direct effect of TAA on the brain must be investigated in further studies. Conversely, the current study used an established model of ALF, providing original data on the involvement of inflammation in hepatic encephalopathy, notably the participation of chemokines.
In conclusion, we observed that brain-derived inflammatory cytokines and chemokines are involved in symptoms emergence in ALF, independent of microglial activation. Furthermore astrocytes and endothelial cells are candidates for early players in the physiopathology of ALF associated encephalopathy.
4.
Experimental procedures
Animals and drugs
Eight to twelve week-old, 20-25 g, female C57BL/6 mice were obtained from the Animal Care Facilities of the Institute of Biological Sciences, Universidade Federal de Minas Gerais. Animals were housed in cages in temperature-controlled rooms and received food and water ad libitum. All experiments were approved by the Animal Ethics Committee of the UFMG. Drugs: thioacetamide (TAA; Sigma-Aldrich, St. Louis, MO, USA) was diluted in sodium chloride 0.9% to a concentration of 40 mg/ml. Acute liver failure induction: ALF was induced by intraperitoneal injection of a single dose of 600 mg/kg of TAA. Sodium chloride 0.9% was given as control. All volumes injected were calculated based on each animal weight. To avoid hypoglycemia and dehydration, all animals received 500 μl of sodium chloride 0.9% plus glucose 5% via subcutaneous injection at the moment of TAA administration and every 24 h post-injection. Temperature was maintained using heat pads. At different time-points after TAA, mice were anesthetized (xylazine 10 mg/kg, ketamine 100 mg/kg) and killed for collection of blood, liver and brain samples.
4.2.
Open field test
Open field (Insight Ltda., Ribeirão Preto, SP, Brazil) test was performed as previously described by Hall (1934) and conducted in order to evaluate locomotor activity. Briefly, animals were gently placed in the center of a circular plexiglass arena (30 cm diameter) and left to explore the area for 5 min.
Total distance traveled during open-field activity was automatically analyzed by the ANY-maze s video-tracking software (Stoelting Co., Wood Dale, IL, USA).
Liver histological analysis
Livers were collected 24 h after induction of ALF and fixed by overnight immersion in 10% buffered formalin. Paraffinembedded specimens were prepared and 5.0 μm sections were stained with hematoxylin and eosin (H&E) according to a standard protocol. Liver pathology was assessed by an investigator who was blinded to the experimental treatment groups in an Olympus BX51 microscope (Center Valley, PA, USA).
Alanine aminotransferase assay
The enzyme alanine aminotransferase (ALT) is normally present in the cytoplasm of hepatocytes and increased activity of this enzyme in serum has high specificity as a marker for liver damage. In order to determine the activity of ALT, blood samples were centrifuged at 10,000 Â g for 15 min at 4 1C and the supernatant was collected. Assays were carried out with a kinetic kit (Bioclin Quibasa, Belo Horizonte, MG, Brazil) following the manufacturer's protocol. Briefly, ALT activity is measured by monitoring the rate of NADH oxidation in a coupled reaction system employing lactate dehydrogenase. The oxidation of NADH to NAD þ is accompanied by a decrease in absorbance at 340 nm.
Activated partial thromboplastin time
Citrate-anticoagulated mouse plasma (50 μl) was mixed with 100 μl Dade s Actin reagent (Siemens Healthcare Diagnostics Inc., Tarrytown, NY, USA). After a 2-minute preincubation at 37 1C, 50 μl of 0.02 M CaCl 2 was added and the clotting time was determined.
Prothrombin time
Citrate-anticoagulated mouse plasma (50 μl) was warmed to 37 1C for 1 min and then mixed with 200 μl Thromborel S with calcium (Siemens Healthcare Diagnostics Inc., Tarrytown, NY, USA) and the clotting time was determined.
Transmision electron microscopy
The animals were fully anesthetized and submitted to transcardiac perfusion with saline followed by 2.5% glutaraldehyde/4% paraphormaldehyde in 0.1 M phosphate buffer (pH 7.4). Frontal cerebral cortex was removed and immersed in the same fixative solution overnight at room temperature. Small brain fragments were routinely processed for Epon embedding. Ultrathin sections were contrasted with lead citrate and examined in Biotwin Tecnai G2-12 transmission electron microscope at 80 keV by an investigator who was blinded to the experimental treatment groups.
Serum and brain cytokines and chemokines measurement
To perform the ELISA assay, the right frontal lobe of the brain was homogenized in extraction solution containing aprotinin. The concentration of cytokines (TNF-α, IL-1β) and chemokines (CXCL1, CCL2, CCL3 and CCL5) was determined by ELISA (R&D Systems, Minneapolis, MN, USA) following the manufacturer's procedures. In addition, blood samples were obtained and centrifuged at 10,000 Â g for 15 min at 4 1C. The supernatant was collected for determination of cytokine TNF-α and chemokines CXCL1 and CCL3.
4.9.
Intravital microscopy Intravital microscopy of the cerebral microvasculature was performed as previously described Vilela et al., 2008) . Briefly, treated and non-treated mice were cannulated for the intravenous administration of rhodamine 6G (0.3 mg/kg; Sigma, St. Louis, MO, USA) and dura matter removed to expose the underlying pial vasculature. Leukocyte-endothelium interactions were visualized using an Olympus (Center Valley, PA, USA) model BX40 microscope fitted with a fluorescent light source (epi-illumination at 510-560 nm using a 590 nm emission filter). Rolling leukocytes (cells/min) were defined as white cells moving at a velocity less than that of erythrocytes. Leukocytes were considered to be adherent to the venular endothelium (100 μm) if they remained stationary for 30 s or longer.
Ionized calcium-binding adapter molecule-1 (Iba-1) immunohistochemistry
To study the activation of microglia activation it was used the method of immunohistochemistry and quantification of total cells positive for Iba-1 (1:250, Wako Chemicals Inc., Richmond, VA, USA). The animals were adequately anesthetized and perfused via transcardiac route with 4% paraformaldehyde in 0.1 M phosphate buffer (0.1 M Na 2 PO 4 , 0.1 M NaHPO 4 at pH 7.4). The brains were then removed and immersed in the same fixative solution for 24 h and then transferred to a solution of 30% sucrose. Cryostat-obtained 20-μm-thick sections were collected in cryoprotectant solution. Selected sections of frontal cortex were washed with PBS, incubated in a blocking solution of 1% BSA for 2 h, followed by incubation for 12 h with primary antibodies against Iba-1. After washing, the sections were incubated for 1 h with biotinylated secondary antibody (1:1000; kit, Vector Labs, Burlingame, CA, USA). Afterwards, tissues were subjected to incubation for 1 h with AB complex (1:1000) and revealed with DAB (3,3 0 -diaminobenzidine). The sections were washed in PBS and mounted on slides and coverslips with the aid of mounting means Entelan. The images were analyzed with Zeiss Axioplan light microscope and computer software AxioVision 
Determination of markers of oxidative stress
To indirectly assess the presence of oxidative stress in the brain of TAA-treated mice lipid peroxidation and antioxidant enzymes activity was measured. Superoxide Dismutase (SOD) activity was measured according to Gao et al. (1998) based on the capacity of SOD to inhibit pyrogallol autoxidation using a spectrophotometer at 420 nm. The amount of SOD that inhibited the oxidation of pyrogallol by 50% (relative to the control) was defined as a unit of SOD activity. Glutathione Peroxidase (GSH-Px) activity was measured according to Paglia and Valentine (1967) based on the capacity of GSH-Px to oxidize NAD phosphate (NADPH). The consumption of NADPH was accompanied by a decrease in absorbance at 340 nm. Catalase activity of tissues was measured by the method of Nelson and Kiesow (1972) in which the disappearance of peroxide is followed spectrophotometrically at 240 nm. The consumption of peroxide was accompanied by a decrease in absorbance for 1 min and catalase was defined as the amount of enzyme which decomposed one mol of peroxide been expressed in nmol min À 1 mg À 1 of protein.
The thiobarbituric acid reactive substances (TBARS) are measured as an index of malondialdehyde production and hence lipid peroxidation by the method of Ohkawa et al. (1979) . The reaction product was determined by spectrophotometer at 532 nm.
Statistical analysis
Statistical analysis was performed using one-way ANOVA, with Tukey's post-test, and Student's t-test. P-values less than 0.05 were considered statistically significant. All data are presented as mean7SEM.
